...
首页> 外文期刊>Nuclearmedicine >Radiation exposure in the environment of patients after application of radiopharmaceuticals. Part 2: Therapeutic procedures
【24h】

Radiation exposure in the environment of patients after application of radiopharmaceuticals. Part 2: Therapeutic procedures

机译:应用放射性药物后患者环境中的辐射暴露。第2部分:治疗程序

获取原文
获取原文并翻译 | 示例
           

摘要

AIM: After therapeutical application of radionuclides the patient has to be regarded as a radioactive source. The radiation exposure differs from diagnostic nuclear medicine due to the amount of radioactivity and due to beta-radiation. Measurements of photon dose rates were carried out and estimates of beta-radiation outside the patient using Monte-Carlo methods. Calculations of maximum beta-ranges in tissue were also performed. Detailed knowledge of the radiation exposure close to the patient is of major importance with respect to radiation protection of the staff. METHOD: Photon dose rates for 32 patients were determined after treatment with [131I]NaI and [131I]meta-iodobenzylguanidin, [32P]Na2HPO4, [90Y]Zevalin and [153Sm]EDTMP. Readings were taken immediately after application at eight distances. RESULTS: For therapies with 131I photon dose rates amount to 2 mSv.h(-1).GBq(-1) close to the patient. Taking the typical activities of 3.7 GBq for thyroid carcinoma and up to 11 GBq for mIBG therapies into account this leads to a considerable radiation exposure of approximately 7.5 mSv/h and 20 mSv/h, respectively. At a distance of 2 m the dose rates fall to 1/100 compared to the vicinity. For 153Sm the maximum of 100 microSv.h(-1).GBq(-1) is significantly lower compared to therapies using radioiodine. After application of 32P or 90Y all photon dose rates are lower (<10 microSv.h(-1).GBq(-1)) but in both cases high energy beta-particles associated with high maximum ranges exceeding 1 cm in tissue have to be considered. CONCLUSION: The remarkable difference of the dose rates in the vicinity of the radioactive patient compared to readings at 2 m distance underlines the major importance of the distance for radiation protection. After application of nuclides emitting high energy beta-particles their contribution outside the patient should be considered. For typical procedures in the patient's vicinity the radiation exposure of the personnel remains below the annual limit of 20 mSv.
机译:目的:在放射性核素的治疗应用后,必须将患者视为放射源。放射线的暴露量与放射诊断的核医学不同,这是由于放射量和β射线辐射所致。使用蒙特卡洛方法进行了光子剂量率的测量并估算了患者体外的β辐射。还进行了组织中最大β范围的计算。关于工作人员的辐射防护,对患者附近的辐射暴露的详细了解至关重要。方法:用[131I] NaI和[131I]间碘苄基胍,[32P] Na2HPO4,[90Y] Zevalin和[153Sm] EDTMP治疗后,确定32例患者的光子剂量率。施用后立即在八距离处读取读数。结果:对于131I光子剂量率的治疗,接近患者的剂量为2 mSv.h(-1).GBq(-1)。考虑到甲状腺癌的3.7 GBq和mIBG疗法的11 GBq的典型活性,这分别导致大约7.5 mSv / h和20 mSv / h的大量辐射暴露。与附近区域相比,在2 m处的剂量率下降到1/100。对于153Sm,与使用放射性碘疗法相比,最大100 microSv.h(-1).GBq(-1)明显更低。应用32P或90Y后,所有光子剂量率均较低(<10 microSv.h(-1).GBq(-1)),但在两种情况下,与组织中超过1 cm的最大最大范围相关的高能β粒子被考虑。结论:与2 m距离处的读数相比,放射性患者附近剂量率的显着差异强调了该距离对于辐射防护的重要意义。在施加发射高能β粒子的核素后,应考虑其在患者体外的贡献。对于患者附近的典型手术,人员的辐射暴露保持在年限值20 mSv以下。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号